Indfrag Biosciences Private
Indfrag Biosciences Private, headquartered in India, is a prominent player in the biotechnology and pharmaceutical industry. Founded in 2008, the company has established itself as a leader in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and nutraceuticals. With a strong operational presence across various regions, Indfrag is committed to innovation and excellence in its core offerings. The company’s unique approach combines advanced technology with rigorous quality control, ensuring that its products meet the highest industry standards. Indfrag's portfolio includes a diverse range of APIs and herbal extracts, catering to both domestic and international markets. Recognised for its commitment to sustainability and research-driven solutions, Indfrag Biosciences continues to strengthen its market position, contributing significantly to the global biosciences landscape.
DitchCarbon Score
How does Indfrag Biosciences Private's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Indfrag Biosciences Private's score of 1 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Indfrag Biosciences Private's reported carbon emissions
In 2023, Indfrag Biosciences Private reported total carbon emissions of approximately 2,182,000 kg CO2e. This figure includes 319,000 kg CO2e from Scope 1 emissions, 476,000 kg CO2e from Scope 2 emissions, and a significant 1,388,000 kg CO2e from Scope 3 emissions. The Scope 3 emissions breakdown reveals major contributions from purchased goods and services (916,080 kg CO2e) and capital goods (111,040 kg CO2e). In 2022, the company recorded total emissions of about 1,615,000 kg CO2e, with Scope 1 emissions at 114,820 kg CO2e, Scope 2 at 350,600 kg CO2e, and Scope 3 emissions reaching 1,149,050 kg CO2e. This indicates a notable increase in emissions from 2022 to 2023. For the years 2021 and 2020, emissions were reported at approximately 1,056,000 kg CO2e and 710,000 kg CO2e, respectively, with Scope 1 and Scope 2 emissions showing a downward trend in 2021 compared to 2020. Despite these figures, Indfrag Biosciences has not disclosed any specific reduction targets or climate pledges, indicating a potential area for improvement in their sustainability strategy. The company’s emissions intensity metrics suggest ongoing efforts to monitor and manage their carbon footprint, but further commitments would enhance their climate action profile.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 137,000 | 00,000 | 000,000 | 000,000 |
| Scope 2 | 573,000 | 000,000 | 000,000 | 000,000 |
| Scope 3 | - | - | 0,000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Indfrag Biosciences Private is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
